Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Khalil Khalaf

1PUBLICATIONS
9CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 16, 2020
CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials.

Khalil Khalaf, Krzysztof Janowicz, Marta Dyszkiewicz-Konwińska

Pageof 1

Frequent Collaborators

1 joint publications

Marta Dyszkiewicz-Konwińska

1 joint publications

Maurycy Jankowski

1 joint publications

Marta Machnik

1 joint publications

Urszula Oleksiewicz

1 joint publications

Ievgeniia Kocherova

1 joint publications

Jim Petitte

1 joint publications

Paul Mozdziak

1 joint publications

Jamil A Shibli

1 joint publications

Mariusz T Skowroński

Frequent Collaborators

1 joint publications

Marta Dyszkiewicz-Konwińska

1 joint publications

Maurycy Jankowski

1 joint publications

Marta Machnik

1 joint publications

Urszula Oleksiewicz

Top Related Videos

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on : Jan 09, 2020

8.3K
See more related videos

Top Related Videos

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on : Jan 09, 2020

8.3K
See more related videos